Naomi Richardson
Overview
Explore the profile of Naomi Richardson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ng S, Price M, Richardson N, Nawaf M, Copland A, Streeter H, et al.
Diabetes
. 2024 Nov;
74(3):384-397.
PMID: 39571092
Article Highlights: There are currently no approved antigen-specific immunotherapies (ASIs) for people with type 1 diabetes (T1D). We aimed to develop a peptide for ASI for T1D based on the...
2.
Abla N, Marrast A, Jambert E, Richardson N, Duparc S, Almond L, et al.
Malar J
. 2024 Sep;
23(1):287.
PMID: 39334094
Plasmodium vivax malaria remains a global health challenge, with approximately 6.9 million estimated cases in 2022. The parasite has a dormant liver stage, the hypnozoite, which reactivates to cause repeated...
3.
Abla N, Almond L, Bonner J, Richardson N, Wells T, Mohrle J
Clin Transl Sci
. 2024 Jul;
17(7):e13865.
PMID: 39020517
The urgent need for safe, efficacious, and accessible drug treatments to treat coronavirus disease 2019 (COVID-19) prompted a global effort to evaluate drug repurposing opportunities. Pyronaridine and amodiaquine are both...
4.
Achan J, Barry A, Leroy D, Kamara G, Duparc S, Kaszubska W, et al.
Malar J
. 2024 Jun;
23(1):174.
PMID: 38835069
Background: Severe malaria is a life-threatening infection, particularly affecting children under the age of 5 years in Africa. Current treatment with parenteral artemisinin derivatives is highly efficacious. However, artemisinin partial...
5.
Ramharter M, Djimde A, Borghini-Fuhrer I, Miller R, Shin J, Aspinall A, et al.
Malar J
. 2024 Feb;
23(1):61.
PMID: 38418982
Background: Children are particularly at risk of malaria. This analysis consolidates the clinical data for pyronaridine-artesunate (PA) paediatric granules in children from three randomized clinical trials and a real-world study...
6.
Davies S, Ronca V, Wootton G, Krajewska N, Bozward A, Fiancette R, et al.
Nat Commun
. 2024 Jan;
15(1):853.
PMID: 38286990
The presence of CD8 T cells in the cytoplasm of biliary epithelial cells (BEC) has been correlated with biliary damage associated with primary biliary cholangitis (PBC). Here, we characterise the...
7.
Chandiwana N, Kruger C, Richardson N, Nxumalo S, Mashilo N, Dineka Y, et al.
Trials
. 2023 Oct;
24(1):635.
PMID: 37794489
Background: Repeated COVID-19 waves and corresponding mitigation measures have impacted health systems globally with exceptional challenges. In response to the pandemic, researchers, regulators, and funders rapidly pivoted to COVID-19 research...
8.
Richardson N, Wraith D
Immunother Adv
. 2022 Aug;
1(1):ltab009.
PMID: 35919740
Targeted restoration of immunological tolerance to self-antigens or innocuous environmental allergens represents the ultimate aim of treatment options in autoimmune and allergic disease. Antigen-specific immunotherapy (ASI) is the only intervention...
9.
Richardson N, Ng S, Wraith D
Front Immunol
. 2020 Aug;
11:1586.
PMID: 32793226
The liver is a critical organ in controlling immune tolerance. In particular, it is now clear that targeting antigens for presentation by antigen presenting cells in the liver can induce...
10.
Ward A, Asif A, Cattermole R, Chima J, Ebbatson T, Mahi I, et al.
Educ Prim Care
. 2020 Aug;
31(5):318-322.
PMID: 32741265
Background Social prescribing is a means of enabling primary care professionals to refer people to a range of local, non-clinical services. Medical students at a large GP surgery in Corby...